Meeting Information

The ISBD will hold its 2nd biennial regional conference in Edinburgh in 2006 ...[More Details]

ISBD Australian Regional Group Conference
Please see details below

6th International Conference on Bipolar Disorder
ISBD Australian Regional Group Conference Highlights
5th International Conference on Bipolar Disorder
4th International Conference on Bipolar Disorder

Highlights from the First ISBD Regional Group
   Conference in Sydney Australia:

With nearly 450 attendees, the first stand alone conference of the ISBD was a tremendous success. [More]

Sixth International Conference on Bipolar Disorder:

SAVE THE DATE: The 6th International Conference on Bipolar Disorder has been set for Thursday through Saturday, June 16-18, 2005. This conference will be held at the David Lawrence Convention Center in Pittsburgh, Pennsylvania, USA.

* Hear from national and international leaders in the field
* New and innovative workshops
* Continuing education Credits available
* Abstract submission deadline is January 14th, 2005

For more information please visit the conference website at www.6thbipolar.org. This conference is hosted by Western Psychiatric Institute and Clinic

Highlights of the 2003 Conference:

We are happy to report that the 5th International Conference on Bipolar Disorder was a tremendous success, with approximately 1000 in attendance. The many esteemed presenters offered a wealth of information on topics ranging from Neuroscience and Genetics to Patient Advocacy. I am also happy to report that the ISBD board and general membership meeting was well attended, with nearly 100 participants.
The board and membership meeting minutes, as well as slides from the presentation, are now available.

We will continue to post coverage of the conference in the weeks and months to come.

Highlights of the 2001 Conference:

ISBD Collaborates in IVth International Conference on Bipolar Disorders

The ISBD presented the first “Mogens Schou Awards for Distinguished Contributions” to the field of bipolar disorders. Three awards were presented in recognition of Professor Schou’s establishment of the first effective treatment for bipolar disorder and his contributions to the field of psychiatry and the treatment of patients with bipolar disorders over the last 50 years. Professor Schou is the Honorary Lifetime President of the ISBD. Professor Schou, himself, was presented with the Founder’s Award. Jules Angst, MD, was given the Mogens Schou Award for Research for his lifetime contributions. Vada and Ted Stanley received the Mogens Schou Award for Distinguished Service to the field of bipolar disorders. E. Fuller Torrey, MD, Executive Director of the Stanley Foundation accepted their award.

Over 800 individuals attended this year’s conference, representing 32 countries. Forty-seven speakers presented at the conference, covering topics such as new approaches to treatment; recent findings in pharmacotherapy; neuroscience; child and adolescent bipolar treatment; multisite treatment sites; regulatory issues in developing drug treatments; and for the first time, advocacy issues.

ISBD members were among the presenters, including:

David J. Kupfer, MD: Conference Chair and ISBD Founding President

Paul E. Keck, MD: Update on Pharmacotherapy

Martha Hellander, JD: Child/Adolescent Bipolar Panel Discussion

Jair C. Soares, MD, ISBD Founding Secretary/Treasurer: Rapid Communications Session Moderator

Michael E. Thase, MD: Chair, Multi-site Treatment Trials

Joseph R. Calabrese, MD: Bipolar Rapid Cycling: Focus on Depression as its Hallmark

Jan Scott, MD, FRCPsych, ISBD Founding and Current Councilor: Non-adherence with Mood Stabilizers: Prevalence, Predictors and Prognosis

Samuel Gershon, MD, ISBD President and Founding Councilor: Chair, Regulatory Issues in Developing Drug Treatments for Bipolar Disorders

Willem A. Nolen, MD, PhD: Panel Discussant, Regulatory Issues in Developing Drug Treatments for Bipolar Disorders

Giovanni B. Cassano, MD, ISBD Founding and Current Councilor: Impact of Anxiety Spectrum Comorbicities on Bipolar Disorder

Per Vestergaard, Dr. Med. Sc: Efficacy Versus Effectiveness in Long-term Lithium Prophylaxis and Related Compliance Issues

Paula J. Clayton, MD: Treatment of Bipolar Disorder Patients in the Young and Middle Adult Years

Bruno Muller-Oerlinghausen, Dr. med., ISBD Founding and Current Councilor: Antisuicidal Effect of Lithium

Atul Pande, MD: Use of Industry Data

Ellen Frank, PhD, ISBD Founding Councilor: Overview -- International Advocacy Forum and presentation on Interpersonal and Social Rhythm Therapy

Paolo Lucio Morselli, MD, ISBD Founding Councilor and Current Vice-President for Global Outreach: Introduction to International Advocacy Forum

Lydia Lewis, National NDMDA Executive Director and ISBD Founding Councilor: The Use of Surveys as an Advocacy Tool

Martha Hellander, JD, Executive Director, The Child and Adolescent Bipolar Foundation: Internet Education, Support and Advocacy

Rasmus W. Licht, MD, PhD: ICD-10 versus DMV-IV diagnostic Criteria for Bipolar Mania: A Clinical Comparison

Valentim Gentil, MD: A Pilot Study for Early Detection and Prevention of Relapse in Sao Paulo State, Brazil

David Miklowitz, PhD: Family Therapy of Bipolar Disorder

Leonardo Tondo, MD: Suicide: From a Historical Background to Modern Prevention

Paolo Cassano, MD: Pramipexole in Treatment-resistant Depression: A 16-Week Naturalistic Study

Anthansio Koukopoulos, MD: Treating the Complex Patient

David Miklowitz, PhD: Moderator, Rapid Communications Session

The first ISBD Board of Councilor's’s meeting was held in conjunction with the conference, as was the first Membership and Business meeting.